Healthcare Genetics in

the NHS Landscape

1st Gengage Network Conference June 2009

Dr Mike WinterMedical Director

National Services Division

Background

• Better Health, Better Care‘as local as possible as specialist as necessary’

• Calman Report– National Advisory Group – National Implementation Group– Education and Training Group– Public Engagement Network

Genetics in NHS Scotland

• National Services Division• Molecular Genetics and Cytogenetics

Laboratory Services Consortium• Clinical Genetics – Assessment, Advice,

and Access to Specialist Services• National Managed Clinical Networks• Cross Border (UK) referrals• Involvement in Research

National Screening

Specialist Servicescomplexity/cost/volume

80 services

Cross Boundary Risk ShareOther National Projects

£114 million Clinical Quality Equity of access

£170 million Clinical Quality Equity of Access

National MCNs

NHS Scotland Genetics Laboratories Consortium

• Access to Appropriate Testing• Quality Assurance of Service• Multi-disciplinary / Multi-professional

Users Group• Professional support and advice

Clinical Genetics

• Local access to high quality Assessment, Advice, and Care across all service

• liaison / referral to other specialist centres when clinically indicated

• Influence planning of Health Services• Active links with Research

Managed Clinical Networks

• Set Standards and Demonstrate improvements in Quality of Care

• Involvement of users and carers• Education and Training for service

providers and others

Cross Border activity

• Recognised list of UK providers of Specialist Gene Tests with agreed referral pathways (no requirement for ‘prior approval’ for most referrals)

• Specialist Clinical Assessment / Treatments can be funded as ‘risk share’

Research

• All parts of NHS Scotland genetics service involved in gene science, clinical and translational research

• NHS Partnerships with both Higher Education and Pharmaceutical industry strong